Alfacalcidol therapy biphasically modifies the relationship between the plasma levels of intact PTH and osteocalcin in dialysis patients.
Kazama
J J
JJ
Takamiya
H
H
D001842:Bone and Bones / Q000187:drug effects; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy*; D015675:Osteocalcin / Q000097:blood*; D010281:Parathyroid Hormone / Q000097:blood*; D006435:Renal Dialysis
D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D015675:Osteocalcin; C008088:alfacalcidol